FDA warns two web­sites sell­ing No­vo, Lil­ly block­buster weight loss drugs

The FDA on Tues­day re­leased two warn­ing let­ters for web­sites sell­ing unau­tho­rized ver­sions of the block­buster weight loss and di­a­betes drugs con­tain­ing semaglu­tide, like Ozem­pic and We­govy.

The two let­ters dat­ed Oct. 2 said the FDA has ob­served that www.go­ril­la­heal­ing.com and www.se­ma­space.com have in­tro­duced in­to in­ter­state com­merce un­ap­proved and mis­brand­ed ver­sions of No­vo Nordisk’s block­busters Ozem­pic, Ry­bel­sus and We­govy, as well as Eli Lil­ly’s Moun­jaro (tirzepatide).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER